Efficacy News and Research

RSS
Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Multimedia talking touchscreens help end health disparities in underserved populations

Multimedia talking touchscreens help end health disparities in underserved populations

Phase III study results of imiquimod creams for treatment of EGW presented at HPV Conference

Phase III study results of imiquimod creams for treatment of EGW presented at HPV Conference

Pioneer Surgical Technology expands Biologics Product Specialist program

Pioneer Surgical Technology expands Biologics Product Specialist program

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Hormonal contraceptives are less effective for birth control in overweight or obese women: Study

Hormonal contraceptives are less effective for birth control in overweight or obese women: Study

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

Patients enrolled in CLARITY-AF study

Patients enrolled in CLARITY-AF study

IRIC scientists identify vitamin B3 as potential antifungal treatment

IRIC scientists identify vitamin B3 as potential antifungal treatment

WSBI, University of Colorado sign licensing agreement for TCISM targets

WSBI, University of Colorado sign licensing agreement for TCISM targets

Alimera Sciences submits MAA for Iluvien to MHRA

Alimera Sciences submits MAA for Iluvien to MHRA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.